Multi-factor combined biomarker screening strategy to rapidly diagnose Alzheimer's disease and evaluate drug effect based on a rat model

Alzheimer's disease (AD) represents the main form of dementia; however, valid diagnosis and treatment measures are lacking. The discovery of valuable biomarkers through omics technologies can help solve this problem. For this reason, metabolomic analysis using ultra-performance liquid chromatog...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yanmeng, Zhang, Xinyue, Lin, Weiwei, Kehriman, Nurmuhammat, Kuang, Wen, Ling, Xiaomei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Xi'an Jiaotong University 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463486/
https://www.ncbi.nlm.nih.gov/pubmed/36105160
http://dx.doi.org/10.1016/j.jpha.2022.04.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463486/
https://www.ncbi.nlm.nih.gov/pubmed/36105160
http://dx.doi.org/10.1016/j.jpha.2022.04.003

Ejemplares similares